Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

Quest Diagnostics Incorporated (DGX) vs Revvity Inc. (RVTY)

Quest Diagnostics Incorporated and Revvity Inc. are both Diagnostics & Research companies. Quest Diagnostics Incorporated is the larger, with a market value of $26.2B against $16.8B — 1.6× the size. Quest Diagnostics Incorporated trades at the lower P/E: 24.8× against 72.0×. Quest Diagnostics Incorporated grew revenue faster over the last twelve months: 9.87% against 4.05%. Quest Diagnostics Incorporated has the higher net margin (9.15% vs 8.16%) and the higher return on invested capital (7.94% vs 2.38%). Both pay a dividend; Quest Diagnostics Incorporated yields more (2.30% vs 0.27%). Across the 23 metrics below, Quest Diagnostics Incorporated leads on 18 and Revvity Inc. on 5.

Valuation

Metric DGX RVTY Diagnostics & Research median
P/E 24.77 71.96 33.95
P/S 2.27 5.79 4.87
P/B 3.35 2.33 3.12
Price to free cash flow 19.45 29.84 34.02
EV/EBITDA 14.14 24.55 25.20
EV/Sales 2.70 6.54 5.66
Earnings yield 4.04% 1.39% (1.75%)
Free cash flow yield 5.14% 3.35% (0.13%)

Profitability

Metric DGX RVTY Diagnostics & Research median
Gross margin 33.11% 54.98% 50.89%
Operating margin 14.10% 12.32% (8.57%)
Net margin 9.15% 8.16% (6.37%)
Free cash flow margin 11.67% 19.58% 0.00%
Return on equity 14.03% 3.21% (2.92%)
Return on assets 6.43% 1.95% (6.71%)
Return on invested capital 7.94% 2.38% 0.00%

Growth

Metric DGX RVTY Diagnostics & Research median
Revenue growth (TTM) 9.87% 4.05% 7.69%
EPS growth (last fiscal year) 13.78% (5.91%) —
Revenue growth, 5-year CAGR 3.18% 1.41% 7.40%
Net income growth, 5-year CAGR (7.06%) (19.82%) 0.00%

Health

Metric DGX RVTY Diagnostics & Research median
Debt to equity 0.72 0.44 0.11
Current ratio 1.59 1.80 2.02
Net debt to EBITDA 2.47 3.00 0.78

Dividend

Metric DGX RVTY Diagnostics & Research median
Dividend yield 2.30% 0.27% 0.70%
Payout ratio 0.29 0.05 0.00

Size

Metric DGX RVTY Diagnostics & Research median
Market cap 26.19b 16.81b 2.56b

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack